SCHEMBL31507772

SCHEMBL31507772

Cc1ccc(-c2ccn3nc(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)nc3c2)c(F)c1OCCC(F)(F)C(O)c1ccc(F)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31507731 0.89 TDP2 (0.32) —
SCHEMBL31507689 0.88 CSNK2A2 (0.30) —
SCHEMBL31507775 0.87 — —
SCHEMBL29498056 0.86 RIPK1 (0.32) —
SCHEMBL29497991 0.86 RIPK1 (0.32) —
SCHEMBL31507760 0.85 CTSA (0.32) —
SCHEMBL31507941 0.84 TDP2 (0.32) —
SCHEMBL31507751 0.84 — —
SCHEMBL31507877 0.83 PIK3CG (0.35) —
SCHEMBL31507847 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072392-A1 TRIAZOLOPYRIDINYL ETHER LINKED COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 — — WO disclosed
Send feedback